Global Ulcerative Colitis Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ulcerative Colitis Revenue
1.4 Market by Type
1.4.1 Global Ulcerative Colitis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Ulcerative Colitis Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Drugs Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ulcerative Colitis Market Perspective (2015-2026)
2.2 Global Ulcerative Colitis Growth Trends by Regions
2.2.1 Ulcerative Colitis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ulcerative Colitis Historic Market Share by Regions (2015-2020)
2.2.3 Ulcerative Colitis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Ulcerative Colitis Market Growth Strategy
2.3.6 Primary Interviews with Key Ulcerative Colitis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ulcerative Colitis Players by Market Size
3.1.1 Global Top Ulcerative Colitis Players by Revenue (2015-2020)
3.1.2 Global Ulcerative Colitis Revenue Market Share by Players (2015-2020)
3.1.3 Global Ulcerative Colitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ulcerative Colitis Market Concentration Ratio
3.2.1 Global Ulcerative Colitis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ulcerative Colitis Revenue in 2019
3.3 Ulcerative Colitis Key Players Head office and Area Served
3.4 Key Players Ulcerative Colitis Product Solution and Service
3.5 Date of Enter into Ulcerative Colitis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ulcerative Colitis Historic Market Size by Type (2015-2020)
4.2 Global Ulcerative Colitis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ulcerative Colitis Market Size by Application (2015-2020)
5.2 Global Ulcerative Colitis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ulcerative Colitis Market Size (2015-2020)
6.2 Ulcerative Colitis Key Players in North America (2019-2020)
6.3 North America Ulcerative Colitis Market Size by Type (2015-2020)
6.4 North America Ulcerative Colitis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ulcerative Colitis Market Size (2015-2020)
7.2 Ulcerative Colitis Key Players in Europe (2019-2020)
7.3 Europe Ulcerative Colitis Market Size by Type (2015-2020)
7.4 Europe Ulcerative Colitis Market Size by Application (2015-2020)
8 China
8.1 China Ulcerative Colitis Market Size (2015-2020)
8.2 Ulcerative Colitis Key Players in China (2019-2020)
8.3 China Ulcerative Colitis Market Size by Type (2015-2020)
8.4 China Ulcerative Colitis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ulcerative Colitis Market Size (2015-2020)
9.2 Ulcerative Colitis Key Players in Japan (2019-2020)
9.3 Japan Ulcerative Colitis Market Size by Type (2015-2020)
9.4 Japan Ulcerative Colitis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ulcerative Colitis Market Size (2015-2020)
10.2 Ulcerative Colitis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ulcerative Colitis Market Size by Type (2015-2020)
10.4 Southeast Asia Ulcerative Colitis Market Size by Application (2015-2020)
11 India
11.1 India Ulcerative Colitis Market Size (2015-2020)
11.2 Ulcerative Colitis Key Players in India (2019-2020)
11.3 India Ulcerative Colitis Market Size by Type (2015-2020)
11.4 India Ulcerative Colitis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ulcerative Colitis Market Size (2015-2020)
12.2 Ulcerative Colitis Key Players in Central & South America (2019-2020)
12.3 Central & South America Ulcerative Colitis Market Size by Type (2015-2020)
12.4 Central & South America Ulcerative Colitis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Johnson & Johnson.
13.1.1 Johnson & Johnson. Company Details
13.1.2 Johnson & Johnson. Business Overview
13.1.3 Johnson & Johnson. Ulcerative Colitis Introduction
13.1.4 Johnson & Johnson. Revenue in Ulcerative Colitis Business (2015-2020))
13.1.5 Johnson & Johnson. Recent Development
13.2 AbbVie
13.2.1 AbbVie Company Details
13.2.2 AbbVie Business Overview
13.2.3 AbbVie Ulcerative Colitis Introduction
13.2.4 AbbVie Revenue in Ulcerative Colitis Business (2015-2020)
13.2.5 AbbVie Recent Development
13.3 Takeda Pharmaceuticals
13.3.1 Takeda Pharmaceuticals Company Details
13.3.2 Takeda Pharmaceuticals Business Overview
13.3.3 Takeda Pharmaceuticals Ulcerative Colitis Introduction
13.3.4 Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020)
13.3.5 Takeda Pharmaceuticals Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Ulcerative Colitis Introduction
13.4.4 Roche Revenue in Ulcerative Colitis Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Warner Chilcott
13.5.1 Warner Chilcott Company Details
13.5.2 Warner Chilcott Business Overview
13.5.3 Warner Chilcott Ulcerative Colitis Introduction
13.5.4 Warner Chilcott Revenue in Ulcerative Colitis Business (2015-2020)
13.5.5 Warner Chilcott Recent Development
13.6 Salix Pharmaceuticals/Santarus
13.6.1 Salix Pharmaceuticals/Santarus Company Details
13.6.2 Salix Pharmaceuticals/Santarus Business Overview
13.6.3 Salix Pharmaceuticals/Santarus Ulcerative Colitis Introduction
13.6.4 Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2015-2020)
13.6.5 Salix Pharmaceuticals/Santarus Recent Development
13.7 Takeda
13.7.1 Takeda Company Details
13.7.2 Takeda Business Overview
13.7.3 Takeda Ulcerative Colitis Introduction
13.7.4 Takeda Revenue in Ulcerative Colitis Business (2015-2020)
13.7.5 Takeda Recent Development
13.8 Ferring Pharmaceuticals
13.8.1 Ferring Pharmaceuticals Company Details
13.8.2 Ferring Pharmaceuticals Business Overview
13.8.3 Ferring Pharmaceuticals Ulcerative Colitis Introduction
13.8.4 Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020)
13.8.5 Ferring Pharmaceuticals Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview
13.9.3 Pfizer Ulcerative Colitis Introduction
13.9.4 Pfizer Revenue in Ulcerative Colitis Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 InDeX Pharmaceuticals
13.10.1 InDeX Pharmaceuticals Company Details
13.10.2 InDeX Pharmaceuticals Business Overview
13.10.3 InDeX Pharmaceuticals Ulcerative Colitis Introduction
13.10.4 InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020)
13.10.5 InDeX Pharmaceuticals Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Ulcerative Colitis Key Market Segments
Table 2. Key Players Covered: Ranking by Ulcerative Colitis Revenue
Table 3. Ranking of Global Top Ulcerative Colitis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ulcerative Colitis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Injection
Table 7. Global Ulcerative Colitis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Ulcerative Colitis Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Ulcerative Colitis Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Ulcerative Colitis Market Share by Regions (2015-2020)
Table 11. Global Ulcerative Colitis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Ulcerative Colitis Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Ulcerative Colitis Market Growth Strategy
Table 17. Main Points Interviewed from Key Ulcerative Colitis Players
Table 18. Global Ulcerative Colitis Revenue by Players (2015-2020) (Million US$)
Table 19. Global Ulcerative Colitis Market Share by Players (2015-2020)
Table 20. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis as of 2019)
Table 21. Global Ulcerative Colitis by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Ulcerative Colitis Product Solution and Service
Table 24. Date of Enter into Ulcerative Colitis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 27. Global Ulcerative Colitis Market Size Share by Type (2015-2020)
Table 28. Global Ulcerative Colitis Revenue Market Share by Type (2021-2026)
Table 29. Global Ulcerative Colitis Market Size Share by Application (2015-2020)
Table 30. Global Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 31. Global Ulcerative Colitis Market Size Share by Application (2021-2026)
Table 32. North America Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Ulcerative Colitis Market Share (2019-2020)
Table 34. North America Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 35. North America Ulcerative Colitis Market Share by Type (2015-2020)
Table 36. North America Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 37. North America Ulcerative Colitis Market Share by Application (2015-2020)
Table 38. Europe Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Ulcerative Colitis Market Share (2019-2020)
Table 40. Europe Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Ulcerative Colitis Market Share by Type (2015-2020)
Table 42. Europe Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Ulcerative Colitis Market Share by Application (2015-2020)
Table 44. China Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 45. China Key Players Ulcerative Colitis Market Share (2019-2020)
Table 46. China Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 47. China Ulcerative Colitis Market Share by Type (2015-2020)
Table 48. China Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 49. China Ulcerative Colitis Market Share by Application (2015-2020)
Table 50. Japan Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Ulcerative Colitis Market Share (2019-2020)
Table 52. Japan Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Ulcerative Colitis Market Share by Type (2015-2020)
Table 54. Japan Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Ulcerative Colitis Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Ulcerative Colitis Market Share (2019-2020)
Table 58. Southeast Asia Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Ulcerative Colitis Market Share by Type (2015-2020)
Table 60. Southeast Asia Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Ulcerative Colitis Market Share by Application (2015-2020)
Table 62. India Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 63. India Key Players Ulcerative Colitis Market Share (2019-2020)
Table 64. India Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 65. India Ulcerative Colitis Market Share by Type (2015-2020)
Table 66. India Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 67. India Ulcerative Colitis Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Ulcerative Colitis Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Ulcerative Colitis Market Share (2019-2020)
Table 70. Central & South America Ulcerative Colitis Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Ulcerative Colitis Market Share by Type (2015-2020)
Table 72. Central & South America Ulcerative Colitis Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Ulcerative Colitis Market Share by Application (2015-2020)
Table 74. Johnson & Johnson. Company Details
Table 75. Johnson & Johnson. Business Overview
Table 76. Johnson & Johnson. Product
Table 77. Johnson & Johnson. Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 78. Johnson & Johnson. Recent Development
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Takeda Pharmaceuticals Company Details
Table 85. Takeda Pharmaceuticals Business Overview
Table 86. Takeda Pharmaceuticals Product
Table 87. Takeda Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 88. Takeda Pharmaceuticals Recent Development
Table 89. Roche Company Details
Table 90. Roche Business Overview
Table 91. Roche Product
Table 92. Roche Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 93. Roche Recent Development
Table 94. Warner Chilcott Company Details
Table 95. Warner Chilcott Business Overview
Table 96. Warner Chilcott Product
Table 97. Warner Chilcott Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 98. Warner Chilcott Recent Development
Table 99. Salix Pharmaceuticals/Santarus Company Details
Table 100. Salix Pharmaceuticals/Santarus Business Overview
Table 101. Salix Pharmaceuticals/Santarus Product
Table 102. Salix Pharmaceuticals/Santarus Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 103. Salix Pharmaceuticals/Santarus Recent Development
Table 104. Takeda Company Details
Table 105. Takeda Business Overview
Table 106. Takeda Product
Table 107. Takeda Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 108. Takeda Recent Development
Table 109. Ferring Pharmaceuticals Business Overview
Table 110. Ferring Pharmaceuticals Product
Table 111. Ferring Pharmaceuticals Company Details
Table 112. Ferring Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 113. Ferring Pharmaceuticals Recent Development
Table 114. Pfizer Company Details
Table 115. Pfizer Business Overview
Table 116. Pfizer Product
Table 117. Pfizer Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 118. Pfizer Recent Development
Table 119. InDeX Pharmaceuticals Company Details
Table 120. InDeX Pharmaceuticals Business Overview
Table 121. InDeX Pharmaceuticals Product
Table 122. InDeX Pharmaceuticals Revenue in Ulcerative Colitis Business (2015-2020) (Million US$)
Table 123. InDeX Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Ulcerative Colitis Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Ulcerative Colitis Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drugs Stores Case Studies
Figure 7. Ulcerative Colitis Report Years Considered
Figure 8. Global Ulcerative Colitis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Ulcerative Colitis Market Share by Regions: 2020 VS 2026
Figure 10. Global Ulcerative Colitis Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Ulcerative Colitis Market Share by Players in 2019
Figure 13. Global Top Ulcerative Colitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ulcerative Colitis as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Ulcerative Colitis Revenue in 2019
Figure 15. North America Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Ulcerative Colitis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed